Chinese Expert Consensus on Integrated Chinese and Western Medicine for the Treatment of Tic Disorders

Abstract

Objective: Tic disorders are neurodevelopmental conditions that manifest in childhood or adolescence and can significantly impact the quality of life of affected children and their families to varying degrees. Integrated traditional Chinese and Western medicine treatment strategies have demonstrated more pronounced efficacy and better safety profiles. However, there is currently no standardized clinical expert consensus on this approach. To address this, the National Administration of Traditional Chinese Medicine initiated a project, and the China Association of Chinese Medicine assembled a team of authoritative domestic experts to develop this expert consensus, aiming to provide practical and feasible integrated treatment strategies for clinical practice.

Methods: This consensus identified clinical issues through research, conducted literature reviews, and established evidence based on systematic evaluations. Expert surveys, two rounds of Delphi questionnaires, and expert consensus meetings were conducted to formulate a series of recommendations.

Results: We established a multidisciplinary consensus development panel. Based on systematic literature reviews, Delphi questionnaires, and consensus meetings, ten clinical issues were identified. Ultimately, a series of recommendations were developed, considering the balance of benefits and risks, the certainty of evidence, clinical feasibility, accessibility, and clinical acceptability.

Conclusions: These recommendations comprehensively address key issues in the field of integrated traditional Chinese and Western medicine treatment, including indications for the use of Chinese or Western medicine alone or in combination, specific treatment protocols, methods for dose reduction and discontinuation, evaluation intervals, and the management of adverse reactions.

Keywords

expert consensus / integrated Chinese and Western medicine / tic disorders / traditional Chinese medicine

References

[1] J. F. Leckman, “Tic Disorders,” BMJ (Clinical Research Ed) 344 (2012): d7659.

[2] K. R. Müller-Vahl, N. Szejko, C. Verdellen, et al., “European Clinical Guidelines for Tourette Syndrome and Other Tic Disorders: Summary Statement,” European Child & Adolescent Psychiatry 31, no. 3 (2022): 377-382.

[3] T. Pringsheim, M. S. Okun, K. Müller-Vahl, et al., “Practice Guideline Recommendations Summary: Treatment of Tics in People With Tourette Syndrome and Chronic Tic Disorders,” Neurology 92, no. 19 (2019): 896-906.

[4] Z. S. Liu, Y. H. Cui, D. Sun, et al., “Current Status, Diagnosis, and Treatment Recommendation for Tic Disorders in China,” Frontiers in Psychiatry 11 (2020): 774.

[5] F. Li, Y. Cui, Y. Li, et al., “Prevalence of Mental Disorders in School Children and Adolescents in China: Diagnostic Data From Detailed Clinical Assessments of 17,524 Individuals,” Journal of Child Psychology and Psychiatry and Allied Disciplines 63, no. 1 (2022): 34-46.

[6] Z. S. Liu, J. Qin, J. Q. Wang, et al., “Expert Consensus on the Diagnosis and Treatment of Tic Disorders (2017 Practical Edition),” Chinese Journal of Applied Clinical Pediatrics 32, no. 15 (2017): 1137-1140.

[7] R. Kurlan, Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. 2nd ed (New York: Maecel Dekker, 2005).

[8] Y. Guo and Y. N. Guo, “Research Progress on Traditional Chinese Medicine Treatment of Tic Disorders,” Clinical Journal of Chinese Medicine 16, no. 12 (2024): 138-144.

[9] L. W. Zhang and J. Xie, “Systematic Review and Meta-Analysis of the Clinical Efficacy of Integrated Chinese and Western Medicine in Treating Pediatric Tic Disorders,” Clinical Journal of Chinese Medicine 14, no. 03 (2022): 20-24.

[10] Y. Y. Yang, H. Huang, and C. S. Yang, “Quality Evaluation of Guidelines and Expert Consensus on Tic Disorders,” Journal of Pediatric Pharmacy 29, no. 8 (2023): 1-5.

[11] J. P. Higgins, D. G. Altman, P. C. Gøtzsche, et al., “The Cochrane Collaboration's Tool for Assessing Risk of Bias in Randomized Trials,” BMJ (Clinical Research Ed) 343 (2011): d5928.

[12] G. H. Guyatt, A. D. Oxman, G. E. Vist, et al., “GRADE: An Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations,” BMJ (Clinical Research Ed) 336, no. 7650 (2008): 924-926.

[13] G. H. Guyatt, A. D. Oxman, R. Kunz, et al., “Going From Evidence to Recommendations,” BMJ (Clinical Research Ed) 336, no. 7652 (2008): 1049-1051.

[14] R. Xie, Y. Xia, Y. Chen, et al., “The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation,” Pharmacological Research 160 (2020): 105178.

[15] V. Gabbay, J. S. Babb, R. G. Klein, et al., “A Double-blind, Placebo-Controlled Trial of ω-3 Fatty Acids in Tourette's Disorder,” Pediatrics 129, no. 6 (2012): e1493-1500.

[16] A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder [Internet]. 2018, https://clinicaltrials.gov/study/NCT03564132.

[17] F. Sallee, E. Kohegyi, J. Zhao, et al., “Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents,” Journal of Child and Adolescent Psychopharmacology 27, no. 9 (2017): 771-781.

[18] A. Ghanizadeh and A. Haghighi, “Aripiprazole Versus Risperidone for Treating Children and Adolescents With Tic Disorder: A Randomized Double Blind Clinical Trial,” Child Psychiatry and Human Development 45, no. 5 (2014): 596-603.

[19] R. Kurlan, G. Crespi, B. Coffey, et al., “A Multicenter Randomized Placebo-Controlled Clinical Trial of pramipexole for Tourette's Syndrome,” Movement Disorders 27, no. 6 (2012): 775-778.

[20] E. F. Hedderick, C. M. Morris, and H. S. Singer, “Double-Blind, Crossover Study of Clonidine and Levetiracetam in Tourette Syndrome,” Pediatric Neurology 40, no. 6 (2009): 420-425.

[21] A Randomized, Double-blind, Placebo-Controlled Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents [Internet]. 2018, https://clinicaltrials.gov/study/NCT03452943.

[22] A Randomized, Double-Blind, Placebo-Controlled, Flexible Dose Study to Evaluate Efficacy and Safety of Pramipexole Immediate Release (0.125-0.5 mg/Day) Versus Placebo for 6 Weeks in Children and Adolescents (Age 6-17 Inclusive) Diagnosed With Tourette Disorder According to DSM IV Criteria [Internet]. 2007, https://clinicaltrials.gov/study/NCT00558467.

[23] A Multicenter, Randomized, Double-Blind, Flexible-Dosed, Placebo-Controlled, Parallel-Group Clinical Trial Evaluating the Efficacy and Safety of Aripiprazole Oral Solution in Children and Adolescents With Tourette's Syndrome [Internet]. 2018, https://clinicaltrials.gov/study/NCT03487783.

[24] A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome [Internet]. 2016, https://clinicaltrials.gov/study/NCT02679079.

[25] A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Dose Optimization Study to Assess the Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome [Internet]. 2017, https://clinicaltrials.gov/study/NCT03325010.

[26] Q. J. Xiong, L. H. Ding, and S. Liu, “Study of Influence of Jiuweixifeng Granules Combined With Tiapride Hydrochloride Tablets on Neurological Function and Quality of Life of the Children With Tic Disorder,” Medical Forum 22, no. 11 (2018): 1448-1451.

[27] Y. Cao, “Efficacy Observation of Jintong Granules Combined With Tiapride Hydrochloride Tablets in the Treatment of Tic Disorders in Pediatric Patients With Kidney-yin Deficiency and Internal Stirring of Liver Wind Pattern,” Modern Journal of Integrated Traditional Chinese and Western Medicine 27, no. 32 (2018): 3609-3612.

[28] S. X. Guo, S. Y. Hu, H. Liu, et al., “Efficacy and Safety of Choudongning Capsule in Children With Tourette's Syndrome of Spleen Deficiency and Phlegm Accumulation in Phase II Clinic,” Chinese Traditional and Herbal Drugs 49, no. 04 (2018): 891-896.

[29] C. Y. Du, S. Y. Hu, B. J. Zhao, et al., “Clinical Observation of Jiuwei Xifeng Granules in Treatment of Tic Disorder in Children With Kidney-yin Deficiency and Liver-Wind Stirring,” Drugs & Clinic 32, no. 04 (2017): 718-722.

[30] J. H. Li, R. Ma, S. Y. Hu, et al., “Jintong Keli for Treatment of Children Tic Disorder With Deficiency of Kidney Yin and Liver Wind Stirring up Internally Syndrome: A Randomized Double-Blind Controlled Trial,” Journal of Traditional Chinese Medicine 57, no. 10 (2016): 860-863.

[31] N. Yang, R. Ma, S. Y. Hu, et al., “Efficacy and Safety of Choudongning Capsule (CDN) in Children With Tourette's Syndrome of Spleen Deficiency and Phlegm Accumulation,” China Journal of Chinese Materia Medica 41, no. 16 (2016): 3100-3106.

[32] S. Y. Hu, R. Ma, T. Tian, et al., “Phase III Clinical Research of Changma Xifeng Tablets in Treating Multiple Tics With Liver Wind and Sputum Stirring Internally,” Drugs & Clinic 29, no. 09 (2014): 1044-1049.

[33] R. Ma, S. Y. Hu, T. Tian, et al., “Zhidong Tablet and the Placebo Control Treatment of Tic Disorder Children Patients of Internal Disturbance of Gan-Wind With Phlegm Syndrome: A Clinical Study,” Chinese Journal of Integrated Traditional and Western Medicine 34, no. 04 (2014): 426-430.

[34] J. Lv, Q. Q. Zhu, Y. P. Hao, et al., “A Double-Blind, Double-Dummy Clinical Study on the Efficacy of Choudongning Capsule in the Treatment of Tourette Syndrome in Pediatric Patients,” Global Traditional Chinese Medicine 6, no. S1 (2013): 85-86.

[35] Z. H. Ling, Clinical Study of 5-Ling Granule in the Treatment of Tourette Syndrome in Pediatric Patients With Pattern of Wind Stirring due to Liver Hyperactivity and Pattern of Phlegm Fire Disturbing Upwards[D] (Nanjing University of Chinese Medicine, 2012).

[36] Chen YY, Lin X, Sheng LX, editors. Efficacy Observation of 5-Ling Granule in the Treatment of Pediatric Tic Disorders (abstract). Collected Papers from the 9th Annual Academic Conference of Zhejiang Mental Health Association; 2011.

[37] R. Ma, S. Y. Hu, X. W. Wei, et al., “Clinical Observation of Jintong Granules on Treating Tic Disorder in Children,” Global Traditional Chinese Medicine 3, no. 1 (2010): 31-34.

[38] L. Jin, R. Ma, S. Y. Hu, et al., “Clinical Research of Xifeng Zhidong Tablet in Treating Multiple Tics With Liver Wind and Sputum Stirring Internally,” Drugs & Clinic 25, no. 2 (2010): 148-151.

[39] Y. Q. Zhong, W. Z. Zhou, W. G. Hu, et al., “Randomized Double-Blind Controlled Study on Treatment of Tic Disorders in Children With Transcutaneous Patch of Clonidine,” Chinese Journal of Pediatrics 45, no. 10 (2007): 785-787.

[40] W. D. Ji, Y. Li, N. LI, et al., “Olanzapine for Treatment of Tourette Syndrome: A Double-Blind Randomized Controlled Trial,” Chinese Journal of Clinical Rehabilitation 9, no. 4 (2005): 66-68.

[41] D. Tao, T. Zhong, S. Ma, et al., “Randomized Controlled Clinical Trial Comparing the Efficacy and Tolerability of Aripiprazole and Sodium Valproate in the Treatment of Tourette Syndrome,” Annals of General Psychiatry 18 (2019): 24.

[42] D. L. Gilbert, T. K. Murphy, J. Jankovic, et al., “Ecopipam, a D1 Receptor Antagonist, for Treatment of Tourette Syndrome in Children: A Randomized, Placebo-controlled Crossover Study,” Movement Disorders 33, no. 8 (2018): 1272-1280.

[43] T. K. Murphy, T. V. Fernandez, B. J. Coffey, et al., “Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children With Chronic Tic Disorders,” Journal of Child and Adolescent Psychopharmacology 27, no. 9 (2017): 762-770.

[44] M. H. Bloch, K. E. Panza, A. Yaffa, et al., “N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial,” Journal of Child and Adolescent Psychopharmacology 26, no. 4 (2016): 327-334.

[45] Y. Zheng, Z. J. Zhang, X. M. Han, et al., “A Proprietary Herbal Medicine (5-Ling Granule) for Tourette Syndrome: A Randomized Controlled Trial,” Journal of Child Psychology and Psychiatry and Allied Disciplines 57, no. 1 (2016): 74-83.

[46] M. E. Lemmon, M. Grados, T. Kline, et al., “Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome,” Pediatric Neurology 52, no. 06 (2015): 629-634.

[47] S. Z. Wang, F. Qi, J. Li, et al., “Effects of Chinese Herbal Medicine Ningdong Granule on Regulating Dopamine (DA)/Serotonin (5-TH) and Gamma-Amino Butyric Acid (GABA) in Patients With Tourette Syndrome,” BioScience Trends 6, no. 04 (2012): 212-218.

[48] Y. M. Awaad, “Levetiracetam in Tourette Syndrome: A Controlled Double-Blind, Placebo Randomized Study,” European Journal of Neurology 17 (2010): 113.

[49] L. Zhao, A. Li, H. Lv, et al., “Traditional Chinese Medicine Ningdong Granule: The Beneficial Effects in Tourette's Disorder Randomized Double-Blind Multicentre Placebo-Controlled Clinical Trial of the Clonidine Adhesive Patch for the Treatment of Tic Disorders,” Journal of International Medical Research 38, no. 01 (2010): 169-175.

[50] R. Garcia-Lopez, E. Perea-Milla, C. R. Garcia, et al., “New Therapeutic Approach to Tourette Syndrome in Children Based on a Randomized Placebo-Controlled Double-blind Phase IV Study of the Effectiveness and Safety of Magnesium and Vitamin B6,” Trials 10 (2009): 16.

[51] Y. S. Du, H. F. Li, A. Vance, et al., “Randomized Double-blind Multicentre Placebo-Controlled Clinical Trial of the Clonidine Adhesive Patch for the Treatment of Tic Disorders,” Australian and New Zealand Journal of Psychiatry 42, no. 9 (2008): 807-813.

[52] C. L. Smith-Hicks, D. D. Bridges, N. P. Paynter, et al., “A Double Blind Randomized Placebo Control Trial of Levetiracetam in Tourette Syndrome,” Movement Disorders 22, no. 12 (2007): 1764-1770.

[53] R. Nicolson, B. Craven-Thuss, J. Smith, et al., “A Randomized, Double-Blind, Placebo-Controlled Trial of Metoclopramide for the Treatment of Tourette's Disorder,” Journal of the American Academy of Child and Adolescent Psychiatry 44, no. 7 (2005): 640-646.

[54] X. L. Xie, D. H. Wu, X. Peng, et al., “Effects of Metoclopramide on the Symptoms as Well as Intelligence and Memory in Tourette Syndrome,” Chinese Journal of Clinical Rehabilitation 9, no. 40 (2005): 155-157.

[55] A Well-Controlled, Fixed-Dose Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tics Associated With Tourette Syndrome [Internet]. 2018, https://clinicaltrials.gov/study/NCT03571256.

[56] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Flexible-Dose Once-Weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Internet]. 2011, https://clinicaltrials.gov/study/NCT01418339.

[57] A Randomized, Placebo-Controlled Trial to Evaluate the Long-Term (ie, Maintenance) Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette's Disorder [Internet]. 2018, https://clinicaltrials.gov/study/NCT03661983.

[58] T. Zhao, Study on the Clinical Efficacy of Traditional Chinese Medicine Treatment Alone in 286 Pediatric Cases of Tic Disorders and Influencing Factors Associated With Tic Disorders (Tianjin: Tianjin University of Traditional Chinese Medicine, 2022).

[59] W. Y. Wang, Clinical Observation of Self-Made Qingxin Xiegan Decoction in the Treatment of Tic Disorders in Pediatric Patients With Fire Hyperactivity of the Heart and Liver Pattern (Harbin: Heilongjiang University of Chinese Medicine, 2023).

[60] R. Guo, Clinical Efficacy Observation of Spleen-strengthening and Liver-Regulating Therapy in the Treatment of Tic Disorders in Patients With Spleen Deficiency and Liver Hyperactivity Pattern (Shenyang: Liaoning University of Traditional Chinese Medicine, 2023).

[61] F. He, H. H. Huang, Y. J. Qi, et al., “Factors Associated With Refractory Tourette's Syndrome,” Journal of Medical Research 49, no. 06 (2020): 99-104.

[62] Y. T. Tan, Study on Prognosis and Influencing Factors Associated With Tourette's Syndrome (Guangzhou: Guangzhou University of Chinese Medicine, 2012).

[63] X. M. Chen, M. L. Guo, and L. X. Yang, “Investigational Research on Factors Associated With the Onset of Tourette's Syndrome,” Chinese Pediatrics of Integrated Traditional and Western Medicine 3, no. 5 (2011): 385-387.

[64] L. X. Yang, X. M. Chen, Y. T. Tan, et al., “Analysis of Prognosis Influencing Factors of Children With Tourette's Syndrome,” Journal of Guangzhou University of Traditional Chinese Medicine 31, no. 6 (2014): 860-863.

[65] W. Y. Li, L. S. Deng, S. Mo, et al., “Clinical Observation of Integrated Traditional Chinese and Western Medicine Stage-by-Stage Therapy in the Treatment of Children's Tic Disorder,” Journal of Guangzhou University of Traditional Chinese Medicine 30, no. 2 (2013): 157-161.

[66] J. Qiu and R. J. Wang, “Clinical Study of Modified Yinqiao Powder in the Treatment of Tourette's Syndrome,” Journal of Hunan University of Chinese Medicine 37, no. 1 (2017): 62-64.

[67] L. Hu, “Clinical Research of Combining Traditional Chinese and Western Medicine for the Treatment of Children With Tourette's Syndrome,” Journal of Sichuan of Traditional Chinese Medicine 34, no. 10 (2016): 128-130.

[68] M. H. Cao, “Clinical Observation on Modified Chaihu Shugan San in Adjuvant Treatment of 102 Cases of Tic Disorder in Children With Stagnation of the Liver-Qi and Deficiency of the Spleen Type,” Journal of Pediatrics of Traditional Chinese Medicine 15, no. 2 (2019): 71-73.

[69] J. Z. Zhang, Clinical Observation of Gouteng Dingfeng Decoction in the Treatment of Tourette's Syndrome in Patients With Pattern of Wind-Stirring Due to Liver Hyperactivity (Zhejiang Chinese Medical University, 2019).

[70] L. L. Gai, “Clinical Efficacy of Changma Xifeng Tablet Combined With Clonidine Transdermal Patch in the Treatment of Children With Tic Disorder,” Chinese Journal of Modern Drug Application 17, no. 19 (2023): 153-156.

[71] L. Yin, R. Xu, H. Yang, et al., “Clinical Study of Changma Xifeng Tablets Combined With Tiapride in the Treatment of Multiple Tourette's Syndrome in Children,” Drugs & Clinic 38, no. 09 (2023): 2212-2217.

[72] A. H. Zhao, C. Zhou, and L. Cao, “Clinical Efficacy Analysis of Shaoma Zhijing Granules Combined With Tiapride in the Treatment of Children With Tic Disorder,” Systems Medicine 8, no. 05 (2023): 131-134.

[73] D. W. Kong, B. Li, Y. L. Du, et al., “Clinical Efficacy Observation of Shaoma Zhijing Granules Combined With Tiapride in the Treatment of Tic Disorders in Pediatric Patients,” Journal of China Prescription Drug 20, no. 08 (2022): 149-151.

[74] Y. X. Zhang, S. Y. Gao, S. Zhang, et al., “Clinical Study of Shaomazhijing Granules Combined With Tiapride in the Treatment of Tourette's Syndrome in Children,” Drugs & Clinic 37, no. 03 (2022): 521-525.

[75] R. B. Huang, S. H. Ge, and C. S. Fang, “Clinical Therapeutic Effect Analysis of Treating Pediatric Tourette's Disease by Combined Use of Tiapride and Jingling Oral Liquid,” China & Foreign Medical Treatment 36, no. 36 (2017): 137-139. 42.

[76] T. Y. Chen, H. M. Ruan, X. M. Han, et al., “Multicenter Observation of the Clinical Effects of Xiaoer Zhili Syrup in the Treatment of Children Tic Disorder With Syndrome of Stirring Wind due to Yin Deficiency,” China Journal of Traditional Chinese Medicine and Pharmacy 34, no. 12 (2019): 5983-5986.

[77] W. P. Xiang and L. Yao, “Clinical Observation of Xiaoer Zhili Syrup Combined With Topiramate in the Treatment of Children With Tic Disorder,” Drugs & Clinic 32, no. 03 (2017): 447-450.

[78] Z. H. Chen, X. F. Zhu, G. S. Yu, et al., “The Curative Effect of Dimuningshen Oral Liquid Combined With Tiopride in the Treatment of Children With Tourette's Disorder,” Zhejiang Clinical Medical Journal 22, no. 11 (2020): 1578-1579. 82.

[79] R. X. Li, Clinical Efficacy Observation of Changma Xifeng Tablets Combined With Psychological and Behavioral Interventions in the Treatment of Tourette's Syndrome in Patients With Pattern of Wind Stirring Due to Liver Hyperactivity (Shanxi University of Chinese Medicine, 2019).

[80] Y. Zhang, “Clinical Observation on 35 Cases of Children With Gilles de la Tourette's Syndrome Treated by Acupuncture Treatment Combined With Haloperidol,” Journal of Pediatrics of Traditional Chinese Medicine 15, no. 02 (2019): 74-77.

[81] D. Wang, Clinical Controlled Study of Scalp Acupuncture Combined With Tiapride in the Treatment of Tourette's Syndrome (Hubei University of Chinese Medicine, 2018).

[82] J. Y. Guan, Clinical Study of Auricular Point Sticking Combined With Tiapride Hydrochloride in the Treatment of Tic Disorders in School-Age Pediatric Patients (Zhejiang Chinese Medical University, 2018).

[83] J. B. Xu, Study on the Distribution Characteristics of Traditional Chinese Medicine Syndrome and Medication Rule for Refractory Tic Disorders in Pediatric Patients (Tianjin University of Traditional Chinese Medicine, 2022).

[84] R. Ma and X. L. Zhang, “Discussion on Pathomechanism Hypothesis ADHD Caused by Growth Retardation of Spinal Marrow,” China Journal of Traditional Chinese Medicine and Pharmacy no. 8 (2008): 737-739.

[85] C. Gao, Y. L. Wu, Y. Q. Wei, et al., “Efficacy Observation of Jingling Oral Liquid Combined With Haloperidol in the Treatment of Tourette's Syndrome in Pediatric Patients,” Modern Journal of Integrated Traditional Chinese and Western Medicine 28, no. 2 (2019): 192-194.

[86] Y. Sun, H. P. Wang, L. F. Duan, et al., “Therapeutic Effect of Pediatric Intellectual Syrup Combined With Aripiprazole on Children With Tic Disorder and Its Effect on Immune Function,” Journal of Medical Information 32, no. 20 (2019): 139-141.

[87] J. Chen, “Efficacy Observation of Tiapride Combined With Xiaoer Huanglong Granules in the Treatment of Tic Disorders With Comorbid Attention Deficit Hyperactivity Disorder,” Journal of Modern Medicine & Health 36, no. 7 (2020): 1033-1035.

[88] C. S. Yang, Evidence-Based Development of Clinical Medication Pathway and Adherence Management Strategies for Pediatric Tic Disorders (Sichuan University, 2021).

[89] Z. N. Xu, Y. Q. Zhao, S. Y. Chen, et al., “Advantage and Risk Analysis on Combination of Traditional Chinese Medicines and Western Medicines,” Chinese Traditional and Herbal Drugs 54, no. 2 (2023): 408-415.

[90] Q. Lu, D. Sun, and Z. Liu, “Interpretation of Expert Consensus for Diagnosis and Treatment of Tic Disorders in China,” Chinese Journal of Applied Clinical Pediatrics 36, no. 9 (2021): 647-653.

[91] R. Yang, Investigation of Prognosis and Long-term Efficacy Evaluation of Jingxin Zhidong Formula-Based Treatment Regimen in Adult Patients With Tic Disorders (Beijing University of Chinese Medicine, 2021).

[92] Y. X. Zhang, Study on Factors Associated With Tic Disorder Recurrence and the Effects of Traditional Chinese Medicine Treatment on this Recurrence (Tianjin University of Traditional Chinese Medicine, 2021).

[93] X. Wang, Study on Traditional Chinese Medicine Medication Reduction Strategies for Tic Disorders and Factors Associated With Tic Disorder Recurrence (Tianjin University of Traditional Chinese Medicine, 2023).

[94] X. M. Chen, Investigation of Factors Associated With Tourette's Syndrome and Traditional Chinese Medicine Etiology of Tourette's Syndrome: Clinical Integrated Traditional (Chinese and Western Medicine of Guangzhou University of Chinese Medicine, 2009).

[95] F. C. Zhang and L. Yang, “Clinical Experience and Insights on Syndrome Differentiation-Based Treatment of Tourette's Syndrome,” Chinese Pediatrics of Integrated Traditional and Western Medicine 1, no. 2 (2009): 113-115.

[96] C. H. Wang and F. Han, “The Prognostic Analysis on the Treatment of 207 Cases of Tics-Tourette's Syndrome With Chinese Medicine,” Journal of Hunan University of Chinese Medicine 32, no. 2 (2012): 64-65. 9.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.